ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease
2018 ◽
Vol 137
◽
pp. 265-276
◽
Keyword(s):
2015 ◽
Vol 15
(1)
◽
Keyword(s):
2010 ◽
Vol 169
(3)
◽
pp. 1296-1306
◽
Keyword(s):
2009 ◽
Vol 5
(1)
◽
pp. 13-23
◽
Keyword(s):
Keyword(s):